Similar articles for PMID: 11079485

Year	Number of Results
1948	1
1955	2
1956	4
1957	2
1960	1
1962	2
1963	2
1980	1
1981	2
1982	3
1985	2
1986	1
1987	1
1988	2
1992	4
1993	8
1994	12
1995	20
1996	19
1997	13
1998	16
1999	6
2000	11
2001	14
2002	5
2003	9
2004	7
2005	4
2006	7
2007	3
2008	3
2009	1
2010	3
2011	4
2012	1
2014	2
2015	1
2016	2
2021	1
2022	1
2024	0

1

L-3-[123I]Iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: correlation with biochemical activity and comparison with [111In-DTPA-D-Phe1]-octreotide imaging.

Jager PL, Meijer WG, Kema IP, Willemse PH, Piers DA, de Vries EG. Jager PL, et al. J Nucl Med. 2000 Nov;41(11):1793-800. J Nucl Med. 2000. PMID: 11079485 Free article.

2

Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide.

Andersson P, Forssell-Aronsson E, Johanson V, Wängberg B, Nilsson O, Fjälling M, Ahlman H. Andersson P, et al. J Nucl Med. 1996 Dec;37(12):2002-6. J Nucl Med. 1996. PMID: 8970523 Free article.

3

Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998.

Raderer M, Kurtaran A, Leimer M, Angelberger P, Niederle B, Vierhapper H, Vorbeck F, Hejna MH, Scheithauer W, Pidlich J, Virgolini I. Raderer M, et al. J Clin Oncol. 2000 Mar;18(6):1331-6. doi: 10.1200/JCO.2000.18.6.1331. J Clin Oncol. 2000. PMID: 10715305 Clinical Trial.

4

Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers.

Kälkner KM, Janson ET, Nilsson S, Carlsson S, Oberg K, Westlin JE. Kälkner KM, et al. Cancer Res. 1995 Dec 1;55(23 Suppl):5801s-5804s. Cancer Res. 1995. PMID: 7493349

5

[111IN-octreotide and 123I-MIBG scintigraphy in the diagnosis of small intestinal carcinoid tumors--results of a comparative investigation].

Dresel S, Tatsch K, Zachoval R, Hahn K. Dresel S, et al. Nuklearmedizin. 1996 Apr;35(2):53-8. Nuklearmedizin. 1996. PMID: 8721576 German.

6

Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide.

Westlin JE, Janson ET, Arnberg H, Ahlström H, Oberg K, Nilsson S. Westlin JE, et al. Acta Oncol. 1993;32(7-8):783-6. doi: 10.3109/02841869309096136. Acta Oncol. 1993. PMID: 8305227

7

A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.

Bomanji J, Mather S, Moyes J, Ellison D, Grossman A, Britton KE, Besser GM. Bomanji J, et al. J Nucl Med. 1992 Jun;33(6):1121-4. J Nucl Med. 1992. PMID: 1597726 Free article.

8

Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors.

Janson ET, Westlin JE, Ohrvall U, Oberg K, Lukinius A. Janson ET, et al. J Nucl Med. 2000 Sep;41(9):1514-8. J Nucl Med. 2000. PMID: 10994731 Free article.

9

Localization of metastatic gastroenteropancreatic tumours by somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-octreotide.

Hammond PJ, Arka A, Peters AM, Bloom SR, Gilbey SG. Hammond PJ, et al. Q J Med. 1994 Feb;87(2):83-8. Q J Med. 1994. PMID: 8153292

10

In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.

Lastoria S, Vergara E, Palmieri G, Acampa W, Varrella P, Caracò C, Bianco RA, Muto P, Salvatore M. Lastoria S, et al. J Nucl Med. 1998 Apr;39(4):634-9. J Nucl Med. 1998. PMID: 9544670 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

198 results

Results by year